infectious diseases | pharmaphorum

Friday 5 December 2025

infectious diseases

News

GSK pumps £45m into antimicrobial resistance projects

GSK pumps £45m into antimicrobial resistance projects

GSK has revealed the six projects it will fund with the Fleming Initiative on antimicrobial resistance, set up with Imperial College London last year.

News

MSD and Cidara Therapeutics logos

Update: MSD's $9.2bn deal for flu biotech Cidara confirmed

MSD has signed a $9.2 billion takeover deal for Cidara that will bolt on a universal flu prevention candidate in phase 3.

News

malaria in red blood cell

Novartis says novel drug could counter malaria resistance

Novartis has reported what looks like another big step forward in the treatment of malaria, as a drug with a novel mechanism hits the mark in phase 3.

News

Pregnant woman puts her hands over her growing belly in shape of a heart

Moderna drops mRNA jab for CMV after phase 3 fail

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital CMV infections, once touted as a future blockbuster.

News

Enanta Pharmaceuticals

Enanta weakens on RSV treatment trial readout

Shares in Enanta Pharma were sliding this morning after it reported results of a phase 2b trial of its RSV antiviral zelicapavir.

News

Dynavax has GSK's shingles vaccine in its sights

Dynavax has GSK's shingles vaccine in its sights

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax wants to knock off its crown.